Fedratinib

Inrebic

Treatment Description

Fedratinib is a selective oral JAK2 inhibitor that is FDA approved for use in myelofibrosis. It is being studied for use in other indications as well.

Participating Centers

There is one center running trials with this treatment. Enter a location below to view the distance.